批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
| 审批日期 | 提交号 | 审批结论 | 提交分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2021/02/11 |
ORIG-1(原始申请) |
Approval |
|
STANDARD
|
|
|
>>>补充申请<<<
| 审批日期 | 提交号 | 审批结论 | 补充类别或审批类型 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 无 |
与本品相关的专利信息(来自FDA橙皮书Orange Book)
| 关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
| 无 |
与本品治疗等效的药品
>>>活性成分:TREPROSTINIL; 剂型/给药途径:INJECTABLE;INTRAVENOUS, SUBCUTANEOUS; 规格:1MG/ML; 治疗等效代码:AP<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 021272 |
001 |
NDA |
REMODULIN |
TREPROSTINIL |
INJECTABLE;INTRAVENOUS, SUBCUTANEOUS |
1MG/ML |
Prescription |
Yes |
Yes |
AP |
2002/05/21
|
UNITED THERAP |
| 203649 |
001 |
ANDA |
TREPROSTINIL |
TREPROSTINIL |
INJECTABLE;INTRAVENOUS, SUBCUTANEOUS |
1MG/ML |
Prescription |
No |
No |
AP |
2017/11/30
|
SANDOZ |
| 209382 |
001 |
ANDA |
TREPROSTINIL |
TREPROSTINIL |
INJECTABLE;INTRAVENOUS, SUBCUTANEOUS |
1MG/ML |
Discontinued |
No |
No |
AP |
2019/09/24
|
PH HEALTH |
| 206648 |
001 |
ANDA |
TREPROSTINIL |
TREPROSTINIL |
INJECTABLE;INTRAVENOUS, SUBCUTANEOUS |
1MG/ML |
Prescription |
No |
No |
AP |
2019/09/26
|
TEVA PHARMS USA |
| 210214 |
001 |
ANDA |
TREPROSTINIL |
TREPROSTINIL |
INJECTABLE;INTRAVENOUS, SUBCUTANEOUS |
1MG/ML |
Prescription |
No |
No |
AP |
2020/05/22
|
DR REDDYS |
| 211574 |
001 |
ANDA |
TREPROSTINIL |
TREPROSTINIL |
INJECTABLE;INTRAVENOUS, SUBCUTANEOUS |
1MG/ML |
Prescription |
No |
No |
AP |
2021/02/11
|
ALEMBIC GLOBAL |
>>>活性成分:TREPROSTINIL; 剂型/给药途径:INJECTABLE;INTRAVENOUS, SUBCUTANEOUS; 规格:2.5MG/ML; 治疗等效代码:AP<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 021272 |
002 |
NDA |
REMODULIN |
TREPROSTINIL |
INJECTABLE;INTRAVENOUS, SUBCUTANEOUS |
2.5MG/ML |
Prescription |
Yes |
Yes |
AP |
2002/05/21
|
UNITED THERAP |
| 203649 |
002 |
ANDA |
TREPROSTINIL |
TREPROSTINIL |
INJECTABLE;INTRAVENOUS, SUBCUTANEOUS |
2.5MG/ML |
Prescription |
No |
No |
AP |
2017/11/30
|
SANDOZ |
| 209382 |
002 |
ANDA |
TREPROSTINIL |
TREPROSTINIL |
INJECTABLE;INTRAVENOUS, SUBCUTANEOUS |
2.5MG/ML |
Discontinued |
No |
No |
AP |
2019/09/24
|
PH HEALTH |
| 206648 |
002 |
ANDA |
TREPROSTINIL |
TREPROSTINIL |
INJECTABLE;INTRAVENOUS, SUBCUTANEOUS |
2.5MG/ML |
Prescription |
No |
No |
AP |
2019/09/26
|
TEVA PHARMS USA |
| 210214 |
002 |
ANDA |
TREPROSTINIL |
TREPROSTINIL |
INJECTABLE;INTRAVENOUS, SUBCUTANEOUS |
2.5MG/ML |
Prescription |
No |
No |
AP |
2020/05/22
|
DR REDDYS |
| 211574 |
002 |
ANDA |
TREPROSTINIL |
TREPROSTINIL |
INJECTABLE;INTRAVENOUS, SUBCUTANEOUS |
2.5MG/ML |
Prescription |
No |
No |
AP |
2021/02/11
|
ALEMBIC GLOBAL |
>>>活性成分:TREPROSTINIL; 剂型/给药途径:INJECTABLE;INTRAVENOUS, SUBCUTANEOUS; 规格:5MG/ML; 治疗等效代码:AP<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 021272 |
003 |
NDA |
REMODULIN |
TREPROSTINIL |
INJECTABLE;INTRAVENOUS, SUBCUTANEOUS |
5MG/ML |
Prescription |
Yes |
Yes |
AP |
2002/05/21
|
UNITED THERAP |
| 203649 |
003 |
ANDA |
TREPROSTINIL |
TREPROSTINIL |
INJECTABLE;INTRAVENOUS, SUBCUTANEOUS |
5MG/ML |
Prescription |
No |
No |
AP |
2017/11/30
|
SANDOZ |
| 209382 |
003 |
ANDA |
TREPROSTINIL |
TREPROSTINIL |
INJECTABLE;INTRAVENOUS, SUBCUTANEOUS |
5MG/ML |
Discontinued |
No |
No |
AP |
2019/09/24
|
PH HEALTH |
| 206648 |
003 |
ANDA |
TREPROSTINIL |
TREPROSTINIL |
INJECTABLE;INTRAVENOUS, SUBCUTANEOUS |
5MG/ML |
Prescription |
No |
No |
AP |
2019/09/26
|
TEVA PHARMS USA |
| 210214 |
003 |
ANDA |
TREPROSTINIL |
TREPROSTINIL |
INJECTABLE;INTRAVENOUS, SUBCUTANEOUS |
5MG/ML |
Prescription |
No |
No |
AP |
2020/05/22
|
DR REDDYS |
| 211574 |
003 |
ANDA |
TREPROSTINIL |
TREPROSTINIL |
INJECTABLE;INTRAVENOUS, SUBCUTANEOUS |
5MG/ML |
Prescription |
No |
No |
AP |
2021/02/11
|
ALEMBIC GLOBAL |
>>>活性成分:TREPROSTINIL; 剂型/给药途径:INJECTABLE;INTRAVENOUS, SUBCUTANEOUS; 规格:10MG/ML; 治疗等效代码:AP<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 021272 |
004 |
NDA |
REMODULIN |
TREPROSTINIL |
INJECTABLE;INTRAVENOUS, SUBCUTANEOUS |
10MG/ML |
Prescription |
Yes |
Yes |
AP |
2002/05/21
|
UNITED THERAP |
| 203649 |
004 |
ANDA |
TREPROSTINIL |
TREPROSTINIL |
INJECTABLE;INTRAVENOUS, SUBCUTANEOUS |
10MG/ML |
Prescription |
No |
No |
AP |
2017/11/30
|
SANDOZ |
| 209382 |
004 |
ANDA |
TREPROSTINIL |
TREPROSTINIL |
INJECTABLE;INTRAVENOUS, SUBCUTANEOUS |
10MG/ML |
Discontinued |
No |
No |
AP |
2019/09/24
|
PH HEALTH |
| 206648 |
004 |
ANDA |
TREPROSTINIL |
TREPROSTINIL |
INJECTABLE;INTRAVENOUS, SUBCUTANEOUS |
10MG/ML |
Prescription |
No |
No |
AP |
2019/09/26
|
TEVA PHARMS USA |
| 210214 |
004 |
ANDA |
TREPROSTINIL |
TREPROSTINIL |
INJECTABLE;INTRAVENOUS, SUBCUTANEOUS |
10MG/ML |
Prescription |
No |
No |
AP |
2020/05/22
|
DR REDDYS |
| 211574 |
004 |
ANDA |
TREPROSTINIL |
TREPROSTINIL |
INJECTABLE;INTRAVENOUS, SUBCUTANEOUS |
10MG/ML |
Prescription |
No |
No |
AP |
2021/02/11
|
ALEMBIC GLOBAL |